Lantus Injection, Solution
Product Images NDC 50090-0876

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Lantus (NDC 50090-0876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lantus 01)

Chemical structure diagram of insulin glargine showing its two polypeptide chains, A and B. The amino acid sequence is detailed with covalent disulfide bonds indicated between cysteine residues connecting the chains, illustrating the molecular structure of this active ingredient.*

FDA Label Image

Figure (Lantus 02)

A line graph comparing glucose infusion rates (mg/kg/min) over time (hours) after subcutaneous injection for insulin glargine and NPH insulin. The solid line represents insulin glargine, showing a gradual, sustained rate, while the dashed line represents NPH insulin, peaking earlier and declining faster. Observation period ends are marked by triangles on the time axis.*

FDA Label Image

Figure (Lantus 03)

An instructional illustration showing hands removing a cap from a vial, likely demonstrating preparation steps for the injection solution. The image is related to subcutaneous administration of medication, consistent with insulin glargine injection.*

FDA Label Image

Figure (Lantus 04)

An instructional black-and-white line drawing showing hands peeling off a protective seal from the top of a vial. This depicts the step of removing the seal before using the vial, relevant for injectable medications like Lantus insulin glargine 100 units/mL solution for subcutaneous injection.*

FDA Label Image

Figure (Lantus 05)

An instructional illustration showing two hands preparing an injection syringe. One hand holds the syringe barrel while the other hand is pulling the plunger to draw liquid into the syringe. This image likely depicts the preparation step for a subcutaneous injection of a medication such as insulin glargine.*

FDA Label Image

Figure (Lantus 06)

A black-and-white instructional illustration showing a hand holding a syringe and a vial. The syringe needle is inserted into the vial's rubber stopper, with an arrow indicating the action to pull or draw medication into the syringe. This image likely demonstrates drawing insulin glargine solution from a vial for injection.*

FDA Label Image

Figure (Lantus 07)

An instructional line drawing showing a hand holding a syringe with the thumb pressing the plunger, illustrating the method to inject or expel medication from the syringe. An arrow indicates the thumb movement downward on the plunger.*

FDA Label Image

Figure (Lantus 08)

An instructional illustration showing a hand holding a syringe with a needle attached, and the other hand manipulating the syringe plunger. The arrow indicates the direction of plunger movement, suggesting the action of drawing or pushing liquid during preparation or injection.*

FDA Label Image

Figure (Lantus 09)

Instructional illustration showing a person's hand inserting a needle or similar device into a vial or container held by the other hand, likely demonstrating a preparation or injection technique related to the Lantus insulin glargine injection.*

FDA Label Image

Figure (Lantus 10)

An instructional illustration showing a hand holding a syringe and a vial, demonstrating the technique for drawing insulin glargine solution for subcutaneous injection, associated with Lantus 100 IU/mL injection by A-S Medication Solutions.*

FDA Label Image

Figure (Lantus 11)

An instructional diagram showing the components of the Lantus SoloStar insulin glargine injection pen. It details the pen cap, pen needle assembly with protective seal, and pen body including the insulin reservoir, rubber seal, dose window, dosage selector, and injection button.*

FDA Label Image

Figure (Lantus 12)

An instructional illustration showing hands preparing a prefilled injection pen for subcutaneous administration. The image details removal of a cap from the injection pen containing insulin glargine solution. It visually demonstrates the initial steps for using a Lantus 100 units/mL injection pen by A-S Medication Solutions.*

FDA Label Image

Figure (Lantus 13)

An instructional illustration showing hands handling a prefilled syringe of Lantus (insulin glargine) injection solution 100 IU/mL, with a red 'X' over the image suggesting an incorrect technique or action.*

FDA Label Image

Figure (Lantus 14)

An instructional diagram showing a hand holding a Lantus insulin glargine injection pen, demonstrating the step to rotate the dial or cap, indicated by a red upward arrow. This illustrates part of the preparation or dose-setting process for the subcutaneous injection solution.*

FDA Label Image

Figure (Lantus 15)

An instructional illustration showing a subcutaneous injection pen assembly process for Lantus insulin glargine 100 units/mL. The image depicts a pen needle being separated into two parts labeled 'Keep' and 'Discard,' with arrows indicating the direction to pull apart the components before attaching to the injection pen.*

FDA Label Image

Figure (Lantus 16)

An instructional illustration showing a hand preparing a syringe labeled with measurement markings, with an inset zoom focusing on the syringe tip cap being removed. The diagram highlights the step for removing the cap before use.*

FDA Label Image

Figure (Lantus 17)

An instructional diagram showing the adjustment of the dose on an insulin pen. The image depicts a hand turning the dose selector dial, with numbers indicating dose units visible on the pen display, and a red arrow illustrating the direction to turn for dose increase.*

FDA Label Image

Figure (Lantus 18)

An instructional illustration showing a hand holding a syringe filled with medication. The syringe is positioned for a subcutaneous injection, indicated by a red arrow pointing to the left, suggesting the direction of injection.*

FDA Label Image

Figure (Lantus 19)

An illustration showing a hand holding an injection pen, with an arrow indicating to push the plunger and a symbol indicating to wait 10 seconds after injection. The image demonstrates the proper technique for administering a subcutaneous injection using the pen device.*

FDA Label Image

Label Image (Lbl500900876)

Lantus insulin glargine injection, solution, 100 units/mL, by A-S Medication Solutions. The label indicates a product NDC of 50090-0876-0 and states each vial contains 100 units insulin glargine in a 10 mL vial. Storage instructions specify refrigeration at 36 to 46 degrees Fahrenheit and caution against freezing. The label advises discarding after 10 doses and describes the vial as a multiple-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.